Enterprise Innovation | Weill Cornell Medicine

Based in New York City, Weill Cornell Medicine Enterprise Innovation engages and collaborates with Weill Cornell Medicine faculty and trainees while fostering alliances with leaders in the biomedical industry and business and investment community. Our focus is to translate the application of emerging science and new technologies into world-class medical breakthroughs.

Integrating Weill Cornell Medicine’s different teams and resources under a single, united organization, Enterprise Innovation encompasses the entire spectrum of an effective innovation ecosystem. We offer unique opportunities for faculty and trainees to transform their research into medical advances through collaborations.

Enterprise Innovation Metrics from FY21 to FY25

761

New Tech Disclosures

184

Issued US Patents

131

Licenses and Options

NewCo Launches

For Inventors and Innovators

Learn about how to collaborate with our team of top-tier business development professionals to bring your innovations to life.

Two men in dark blue suits shaking hands and two women at the table smiling

For Industry, Investors and Partners

Learn about groundbreaking innovations you can partner to fuel a pipeline or launch a new venture.

A Caucasian and an Indian woman holding some booklets and talking

Innovation Ecosystem

Learn more about the infrastructure and different components of Enterprise Innovation.

Four medical students in white coats sitting at a table and listening to a lecture

Programs, Offerings and Support

Explore entrepreneurial programming and education offered by Enterprise Innovation and our ecosystem partners.

Technology Portfolio

Enterprise Innovation brings together the power of industry-leading translational research and clinical care combined with top-tier business development expertise to accelerate innovation to market. Our leading technology portfolio encompasses major pillars of biomedical innovation.

We also provide access to a diverse selection of tangible materials developed by Weill Cornell Medicine investigators. See the most updated catalog of our ready-for-licensing tangible materials here.

Two doctors and two business reps talking

Collaboration Opportunities

Check out our available research opportunities for potential collaborations.

Events

A Caucasian woman with curly blonde hair wearing a black suit

May 13,2026

4:00pm to 5:30pm

Fireside Chat with Ruth Atherton, Ph.D. '99, J.D., WCGS Alumni

Caucasian man wearing glasses and a gray suit

May 15,2026

11:00am to 1:00pm

Weekly Office Hours on Industry Funded and Sponsored Research

Clear liquid being dropped into test tubes

May 21,2026

12:00pm to 1:00pm

Morrison Foerster Virtual Cell and Gene Therapies Series

Illustration of two scientists in white coats and three others in Oscar style dresses and suit

Jun 02,2026

4:30pm to 10:00pm

America's Got Research

Testimonials

Lisa Placanica, Ph.D., Senior Managing Director of the Center for Technology Licensing

There’s obviously fantastic research being done at Weill Cornell Medicine. So we want to work with faculty to identify aspects of their research that could be shaped into a product or a service, work with them to develop it and then to forge the partnership with a commercial entity. We also have to have a finger on the pulse of what industry is looking for: what venture firms are investing in, what pharma is trying to fill their pipeline with. And then we make connections between the two. We have to speak the language between the commercial enterprise and the academic researcher.

Randi B. Silver, Ph.D., Associate Dean and Professor of Physiology and Biophysics

Enterprise Innovation has galvanized us to move forward as basic scientists, and to look for translational aspects that could be developed, with an industrial partner, for patient care. As a result, we have been able to get traction in exploring various avenues for commercialization with angel investors, pharma, venture capital and, significantly, our own Tri-Institutional Therapeutics Discovery Institute, none of which would have been possible without support from the Daedalus Fund for Innovation.

Ronald G. Crystal, M.D., Chair of Genetic Medicine and Professor of Medicine

Allying with the right industrial partner is a vital factor in attracting investors, and Enterprise Innovation’s relationships with and access to biopharma and life science leaders make it possible for aspiring scientist/entrepreneurs to find the right match.

Juan Cubillos-Ruiz, Ph.D., Associate Professor of Microbiology and Immunology in Obstetrics and Gynecology

With the outstanding support provided by Weill Cornell Medicine’s innovation ecosystem, we identified and developed novel small-molecule inhibitors capable of disabling a detrimental pathway in cancer hosts. We are currently partnering with investors to use our inhibitors as a new strategy for enhancing the effectiveness of chemotherapy and immunotherapy in ovarian cancer and other lethal malignancies.

News

An East Asian man wearing a dark gray suit and tie and a South Asian woman with long black hair and wearing a white suit. Both smiling at the audience.

BioInnovate Conference Showcases Path from Innovation to Scale Through a Growing Ecosystem

May 7, 2026

Over 200 scientists, startup founders and partners in government and industry gathered at Uris Auditorium on April 23 for the 2026 BioInnovate Conference. The event, hosted by BioVenture eLab, part of Weill Cornell Medicine Enterprise Innovation, celebrates the growing ecosystem that turns scientific discovery into scalable healthcare solutions. Speakers and panelists discussed topics ranging from AI in clinical trials to reshoring domestic drug discovery and manufacturing.

An old man wearing VR goggles and a gray suit talking to a group of students standing in a semicircle

Students Design AI-Powered Health Solutions at Cornell Health Hackathon

March 19, 2026

More than 100 students from across Cornell campuses and 17 other universities gathered in New York City March 6–8 for the Cornell Health AI Hackathon. Organized by Entrepreneurship at Cornell with partners including Weill Cornell Medicine’s Englander Institute for Precision Medicine and the Clinical and Translational Science Center, along with Cornell Tech, the event brought together interdisciplinary teams from medicine, engineering, computer science and business.

Translating Research into Next Generation Care Through Collaboration